75 related articles for article (PubMed ID: 202371)
1. Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin.
Johnson PJ; Wansbrough-Jones MH; Portmann B; Eddleston AL; Williams R; Maycook WD; Calne RY
Br Med J; 1978 Jan; 1(6107):216. PubMed ID: 202371
[No Abstract] [Full Text] [Related]
2. [Familial hepatocellular carcinoma with positive surface antigen (HBsAg)].
Sanz Ortiz J; de la Gándara Porres I; Martino E
Med Clin (Barc); 1985 Dec; 85(20):859. PubMed ID: 3003470
[No Abstract] [Full Text] [Related]
3. Liver transplantation in a 27-year-old female with familial HBsAg-positive hepatocellular carcinoma.
Macdougall BR; Johnson PJ; Williams R; Strunin L; Macmaster P; Calne RY; Bronkhorst FB; Katchaki JN; Brandt KH; Houthoff HJ; Piers DA; Schuur KH; Krom RA; Gips CH
Neth J Med; 1978; 21(3):101-16. PubMed ID: 78459
[No Abstract] [Full Text] [Related]
4. Serum Gm system in liver cirrhosis and hepatoma.
Theodoropoulos G; Archimandritis A; Drivas G; Kaliakmanis N; Melissinos K
Hum Genet; 1980; 56(2):217-9. PubMed ID: 6256282
[TBL] [Abstract][Full Text] [Related]
5. Prevention of hepatitis B virus reinfection after orthotopic liver transplantation.
Wang ZX; Ding GS; Fu H; Zhang JJ; Chen XS; Guo WY; Shi XM; Fu ZR
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):345-8. PubMed ID: 15313666
[TBL] [Abstract][Full Text] [Related]
6. HBV-DNA in sera of patients with HBsAg-positive primary liver cell carcinoma.
Theilmann L; Gmelin K; Will H; Czygan P; Hasche G; Doerr HW; Kommerell B
Z Gastroenterol; 1984 Apr; 22(4):182-7. PubMed ID: 6328781
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus infection and chronic liver disease in Taiwan.
Chen DS; Sung JL
Acta Hepatogastroenterol (Stuttg); 1978 Dec; 25(6):423-30. PubMed ID: 214987
[TBL] [Abstract][Full Text] [Related]
8. Orcein staining of hepatitis B surface antigen in paraffin sections of liver on autopsy cases.
Sakurai M; Miyaji T
Acta Hepatogastroenterol (Stuttg); 1977 Oct; 24(5):334-9. PubMed ID: 73335
[TBL] [Abstract][Full Text] [Related]
9. HLA antigen in Chinese patients with hepatocellular carcinomas.
Chan SH; Simons MJ; Oon CJ
J Natl Cancer Inst; 1980 Jul; 65(1):21-3. PubMed ID: 6156260
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective.
Wesdorp DJ; Knoester M; Braat AE; Coenraad MJ; Vossen AC; Claas EC; van Hoek B
J Clin Virol; 2013 Sep; 58(1):67-73. PubMed ID: 23880162
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
12. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
[TBL] [Abstract][Full Text] [Related]
14. Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases.
Sakamoto M; Hirohashi S; Tsuda H; Ino Y; Shimosato Y; Yamasaki S; Makuuchi M; Hasegawa H; Terada M; Hosoda Y
Cancer Res; 1988 Dec; 48(24 Pt 1):7294-7. PubMed ID: 2847867
[TBL] [Abstract][Full Text] [Related]
15. Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver.
Hirohashi S; Shimosato Y; Ino Y; Kishi K
J Natl Cancer Inst; 1982 Sep; 69(3):565-8. PubMed ID: 6287080
[TBL] [Abstract][Full Text] [Related]
16. [A study of familial case histories of hepatocellular carcinoma--285 cases in Saga Prefectural Hospital].
Miyanaga O; Shirahama M; Ishibashi H
Gan No Rinsho; 1990 Feb; 36(2):127-31. PubMed ID: 2155331
[TBL] [Abstract][Full Text] [Related]
17. Effect of cytotoxic chemotherapy on hepatitis B viral markers in patients with hepatocellular carcinoma.
Zaman S; Melia W; Johnson P; White Y; Williams R
Clin Oncol; 1984 Sep; 10(3):247-52. PubMed ID: 6090048
[TBL] [Abstract][Full Text] [Related]
18. [Recurrence of virus B hepatitis after liver transplantation].
Gugenheim J; Crafa F; Fabiani P; Militerno G; Goubaux B; Saint-Paul MC; Ouzan D; Mouiel J
Gastroenterol Clin Biol; 1992; 16(5):430-3. PubMed ID: 1326456
[TBL] [Abstract][Full Text] [Related]
19. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma.
Kubo Y; Okuda K; Hashimoto M; Nagasaki Y; Ebata H
Gastroenterology; 1977 Jun; 72(6):1217-20. PubMed ID: 192626
[TBL] [Abstract][Full Text] [Related]
20. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area.
Paterlini P; Driss F; Nalpas B; Pisi E; Franco D; Berthelot P; Bréchot C
Hepatology; 1993 Jan; 17(1):20-9. PubMed ID: 8380790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
